Vogt-Koyanagi-Harada Syndrome
Article Sidebar
Main Article Content
Abstract
Article Details
References
Sheu SJ. Update on uveomeningoence phalitides. Curr Opin Neurol. 2005 Jun;
(3):323-9.
Vogt A. Fruhzeitiges Ergaruen der Zilien und Bemerkungen uber den sogenaten plotzlichen
Eintreitt dieser Veraderung. Klin Monatsbl Augenheikd. 1906;44:228-42.
Koyanagi Y. Dysakusis, Alopecia und Poliosis bei schwerer Uveitis nicht traumatischen
Ursprugs. Klin Monatsbl Augenheikd. 1929; 82:194-211.
Harada E. Acute diffuse choroiditis. Acta Soc Ophthalmol Jpn. 1926;30:356-78.
Babel J. Sundrome de Vogt-Koyanagi (Uveite bilaterale, poliosis, alopecie, vitiligo et
dyacousie). Schweiz Med Wochenschr Nr.1932;44:1136-40.
Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular
inflammatory disease in Japan. Ocul Immunol Inflamm. 2003 Dec;11(4):277-86.
Murthy SI, Moreker MR, Sangwan VS, Khanna RC, Tejwani S. The spectrum of Vogt-
Koyanagi-Harada disease in South India. Int Ophthalmol. 2007 Apr-Jun;27(2-3):131-6.
Chee SP, Jap A, Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore.
Int Ophthalmol. 2007 Apr-Jun;27(2-3):137-42.
Rajendram R, Evans M, Rao NA. Vogt- Koyanagi-Harada disease. Int Ophthalmol Clin.
Spring;45(2):115-34.
Sukavatcharin S, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease in Hispanic patients.
Int Ophthalmol. 2007 Apr-Jun;27(2-3):143-8.
Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol.
Jul-Sep;20(3):183-90.
Khairallah M, Zaouali S, Messaoud R,Chaabane S, Attia S, Ben Yahia S, et al. The
spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa. Int Ophthalmol. 2007
Apr-Jun;27(2-3):125-30.
Khairallah M, Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, et al. Pattern of uveitis
in a referral centre in Tunisia, North Africa. Eye (Lond). 2007 Jan;21(1):33-9.
Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M, et al. The spectrum of
Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol. 2007
Apr-Jun;27(2-3):117-23.
Tesavibul N, Sansanayuth W. Vogt-Koyanagi- Harada disease in Thai patients. J Med Assoc
Thai. 2005 Nov;88 Suppl 9:S26-30.
Keino H, Nakashima C, Watanabe T, Taki W, Hayakawa R, Sugitani A, et al. Frequency and
clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol. 2009
Aug;37(6):595-601.
Bassili SS, Peyman GA, Gebhardt BM, Daun M, Ganiban GJ, Rifai A. Detection of Epstein-
Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-
Koyanagi-Harada syndrome. Retina. 1996;16(2):160-1.
Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase
peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol.2007 Apr-Jun;27(2-3):87-95.
Sene D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N, et al. Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol. 2007 Jun 14;13(22): 3137-40.
Kasahara A, Hiraide A, Tomita N, Iwahashi H, Imagawa A, Ohguro N, et al. Vogt-
Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis
C. J Gastroenterol. 2004 Nov;39(11):1106-9.
Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are
antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000 Dec 15;165(12):7323-9.
Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, et al. Ocular infiltrating
CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human
melanocyte antigens. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2547-54.
Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res. 2008 Jul;33(7):517-23.
Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006
Spring;46(2):111-22.
Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, et al. IL-23 promotes CD4+ T cells to produce
IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007 May;119(5):1218-24.
Perry HD, Font RL. Clinical and histopathologic observations in severe Vogt-Koyanagi-
Harada syndrome. Am J Ophthalmol. 1977 Feb;83(2):242-54.
Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-
Harada disease. Am J Ophthalmol. 2001 May;131(5):607-14.
Ohno S, Char DH, Kimura SJ, OuConnor GR.Vogt-Koyanagi-Harada syndrome. Am J
Ophthalmol. 1977 May;83(5):735-40.
Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35.
Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Haradaus disease.
Jpn J Ophthalmol. 1988;32(3):334-43.
Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications
and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001 May;131(5):599-606.
Kuo IC, Rechdouni A, Rao NA, Johnston RH, Margolis TP, Cunningham ET, Jr. Subretinal
fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology. 2000 Sep;107(9):
-8.
Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980
Jul;90(1):69-75.
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised
diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee
on nomenclature. Am J Ophthalmol. 2001 May;131(5):647-52.
Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the
appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001 Jan;108(1):54-64.
Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-
Harada syndrome. Arch Ophthalmol. 1990 Oct;108(10):1421-6.
Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-
Harada disease. Ophthalmologica. 1990;201 (3):162-7.
Yamanaka E, Ohguro N, Yamamoto S,Nakagawa Y, Imoto Y, Tano Y. Evaluation of
pulse corticosteroid therapy for vogt-koyanagiharada disease assessed by optical coherence
tomography. Am J Ophthalmol. 2002 Sep;134(3):454-6.
Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, et al. Evaluation of the effect
on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada
disease. Am J Ophthalmol. 2006 Jul;142(1): 119-24.
Biswas J, Roa NA. Management of intraocular inflammation. In: Ryan SJ, editor. Retina. St.
Louis: Mosby-Year book; 1994.
Roa NA, Blackman HJ, Franklin RM, et al. Intraocular inflammation and uveitis. In: Basic
and clinical science course 1998-1999. San Francisco: American Academy of Ophthalmology;
Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-
Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006 Apr;14(2):87-90.